On May 9, 2023, the BPTO released the INPI/CPAPD technical opinion No. 01/2023, which provides guidance on the patentability of inventions related … The Brazilian PTO published a new technical opinion regarding the patentability of inventions related to transgenic plants

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving … Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide

On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the … News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529

After judgment of the DPC 5529, the Federal Supreme Court decided that the provision of the Sole Paragraph of Article 40 of … BPTO allows revision of the term adjustment of patents impacted by the DPC 5529

The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to … ANVISA published manuals related to prior consent of patent applications

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil … Biologics and biosimilars in Brazil – the strategic questions

By means of publication made in the Official Gazette 2,570, dated April 7th, 2020, the Brazilian Patent Office promulgated Ordinance No. 149/2020, … The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19